32 research outputs found
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
OBJECTIVES: The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc).
METHODS: The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcer disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to digital ulcers.
RESULTS: Up to 19 November 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (lcSSc; 52.2%) or diffuse cutaneous SSc (dcSSc; 36.9%). Digital ulcers developed earlier in patients with dcSSc compared with lcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45.2% for anti-scleroderma-70 and 43.6% for anticentromere antibodies (ACA). The first digital ulcer in the anti-scleroderma-70-positive patient cohort occurred approximately 5 years earlier than the ACA-positive patient group.
CONCLUSIONS: This study provides data from a large cohort of SSc patients with a history of digital ulcers. The early occurrence and high frequency of digital ulcer complications are especially seen in patients with dcSSc and/or anti-scleroderma-70 antibodies
Prevalence of Hyperkalaemia in Chronic Haemodialysis Patients
Haemodialysis patients are more likely to suffer from hyperkalaemia than the general population. It puts them at danger of a fatal accident. In haemodialysis, it is not part of the standard examinations. The purpose of our study was to find out how common it was among individuals on long-term dialysis. Our research was cross-sectional in nature. Participants had to have been on haemodialysis for at least two months and be willing to participate in the research. Before the start of their first and second weekly dialysis sessions, we did a clinical examination, blood potassium, sodium, and ionized calcium tests, and an electrocardiogram in each of them. 88 patients were chosen for the study. Before the first dialysis session began, 38.7 percent of patients had hyperkalaemia, and 17 percent had it before the second. In three cases, the blood potassium level was determined to be at least 7.5 mEq / l, indicating that the patient was suffering from a condition known as paresis. Hyperkalaemia is associated with a tall T wave on the ECG in two circumstances. Although hyperkalaemia is widespread in our dialysis patients, its clinical and electrocardiographic symptoms are less so
The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data.
BACKGROUND: The National Comprehensive Cancer Network and the American Society of Clinical Oncology have established guidelines for the treatment and surveillance of colorectal cancer (CRC), respectively. Considering these guidelines, an accurate and efficient method is needed to measure receipt of care. METHODS: The accuracy and completeness of Veterans Health Administration (VA) administrative data were assessed by comparing them with data manually abstracted during the Colorectal Cancer Care Collaborative (C4) quality improvement initiative for 618 patients with stage I-III CRC. RESULTS: The VA administrative data contained gender, marital, and birth information for all patients but race information was missing for 62.1% of patients. The percent agreement for demographic variables ranged from 98.1-100%. The kappa statistic for receipt of treatments ranged from 0.21 to 0.60 and there was a 96.9% agreement for the date of surgical resection. The percentage of post-diagnosis surveillance events in C4 also in VA administrative data were 76.0% for colonoscopy, 84.6% for physician visit, and 26.3% for carcinoembryonic antigen (CEA) test. CONCLUSIONS: VA administrative data are accurate and complete for non-race demographic variables, receipt of CRC treatment, colonoscopy, and physician visits; but alternative data sources may be necessary to capture patient race and receipt of CEA tests